首页/数据集/dataset related to article "Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma"

dataset related to article "Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma"

NIAID Data Ecosystem2026-03-13 收录

肺癌靶向治疗评估

医学影像病例分析

数据链接：

https://zenodo.org/record/6362240 数据链接链接失效反馈

官方服务：

资源简介：

Radiological images of the patient (case report)

应用场景：

创建时间：

2022-03-17

EGFR突变疗效评估

肺癌靶向治疗评估

aHR19/21 of TKI represents HR19 exon deletion/exon 21 L858R mutation in TKI therapy cohort. Abbreviations: CI = confidence interval; EGFR = epidermal growth factor receptor; HR = Hazard ratio; P

NIAID Data Ecosystem70

Univariate analysis of objective response rate of erlotinib treatment in lung adenocarcinoma patients without detectable EGFR mutations at initial molecular testing.

肺癌靶向治疗评估

EGFR突变阴性肺腺癌

ORR, objective response rate; ECOG PS, Eastern Cooperative Oncology Group performance status; NS, nonsmoker; C/FS, current or former smoker; EGFR, epidermal growth factor receptor.aInclude Scorpions A

Figshare2015-12-02 更新00

Figure1&2

眼科遗传病表型

医学影像病例分析

Figure1 & 2 in the paper of "Persistent hyperplastic primary vitreous with microphthalmia and coloboma in a patient with Okur-Chung neurodevelopmental syndrome"

Figshare2021-06-04 更新20

Supplementary Material for: Unusual metastatic lymph node to retro-scapular area in occult breast cancer, a case report

癌转移诊断

医学影像病例分析

Introduction: Breast cancer typically metastases to axillary, internal mammary and supraclavicular lymph node chains. In contrast, occult breast cancer (OBC), a rare form of breast cancer, usually pre

Figshare2024-12-26 更新00

dataset related to article "Carcinomatosis under control by osimertinib in EGFR and TP53 mutated lung adenocarcinoma"

资源简介：

相关数据集